|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 111, Issue 9 1175-1183, Copyright © 1998 by Company of Biologists
JOURNAL ARTICLES |
LM Dahm and CW Bowers
Division of Neurosciences, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.
Previous work from this laboratory has established a method for maintaining physiological contractility of dissociated avian smooth muscle in a defined medium at low density. The present report emphasizes the dramatic potency of serum to alter smooth muscle phenotype and induce a loss of contractility. Vitronectin, a molecule purified from plasma, mimicked these effects of serum via an integrin that is RGD-sensitive. Studies utilizing blocking antibodies against vitronectin demonstrated that the presence of this specific adhesion molecule was necessary for the serum-induced loss of contractility. Based on the actions of function-blocking antibodies and RGD-containing peptides, the integrin alphavbeta1 appears to be the primary receptor involved in vitronectin's ability to induce phenotypic transformation in amniotic smooth muscle. The influence of vitronectin on smooth muscle contractility is particularly relevant, because this molecule is abundant in whole blood and plasma (approx. 400 microg/ml). The results suggest that smooth muscle needs to be continually protected from normal blood constituents in vivo. The implications of these results for smooth muscle-related diseases like atherosclerosis, restenosis and Kaposi's sarcoma are discussed.
This article has been cited by other articles:
|
|
 |
|
  T. Kaido, B. Perez, M. Yebra, J. Hill, V. Cirulli, A. Hayek, and A. M. Montgomery {alpha}v-Integrin Utilization in Human {beta}-Cell Adhesion, Spreading, and Motility J. Biol. Chem., April 23, 2004; 279(17): 17731 - 17737. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Willis, D. Pierre-Paul, B. E. Sumpio, and V. Gahtan Vascular Smooth Muscle Cell Migration: Current Research and Clinical Implications Vascular and Endovascular Surgery, January 1, 2004; 38(1): 11 - 23. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Duque and B. Baxt Foot-and-Mouth Disease Virus Receptors: Comparison of Bovine {alpha}V Integrin Utilization by Type A and O Viruses J. Virol., February 15, 2003; 77(4): 2500 - 2511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Koistinen and J. Heino The Selective Regulation of alpha Vbeta 1 Integrin Expression Is Based on the Hierarchical Formation of alpha V-containing Heterodimers J. Biol. Chem., June 28, 2002; 277(27): 24835 - 24841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dufourcq, T. Couffinhal, P. Alzieu, D. Daret, C. Moreau, C. Duplaa, and J. Bonnet Vitronectin is up-regulated after vascular injury and vitronectin blockade prevents neointima formation Cardiovasc Res, March 1, 2002; 53(4): 952 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. P. Moiseeva Adhesion receptors of vascular smooth muscle cells and their functions Cardiovasc Res, December 1, 2001; 52(3): 372 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Scaffidi, Y. P. Moodley, M. Weichselbaum, P. J. Thompson, and D. A. Knight Regulation of human lung fibroblast phenotype and function by vitronectin and vitronectin integrins J. Cell Sci., January 10, 2001; 114(19): 3507 - 3516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Stringa, V Knauper, G Murphy, and J Gavrilovic Collagen degradation and platelet-derived growth factor stimulate the migration of vascular smooth muscle cells J. Cell Sci., January 6, 2000; 113(11): 2055 - 2064. [Abstract] [PDF]
|
|
